We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Left Hemi-Hepatectomy to Resect Metastatic Tumor of Round Ligament of Liver in Patients with Ovarian Cancer.
- Authors
Kim, Uisuk; Bae, Jae Kyung; Kim, Junhwan; Kim, Ji Hyun; Kim, Seong Hoon; Han, Sung-Sik; Park, Hyeong Min; Park, Sang-Yoon; Lim, Myong Cheol
- Abstract
Simple Summary: This study suggests that left hemi-hepatectomy should be discussed preoperatively and intraoperatively for the complete resection of a metastatic tumor around the round ligament of the liver. We explain the necessity of left hemi-hepatectomy by the critical vascular anatomy and the pathological report of this study. The objective of this study is to investigate the surgical, clinical and pathological outcomes of left hemi-hepatectomy during cytoreductive surgery (CRS) in patients with primary ovarian cancer. The electronic medical charts of patients with primary ovarian cancer who received CRS including left hemi-hepatectomy from 2000 to 2023 were reviewed and retrospectively analyzed. A total of 17 patients underwent left hemi-hepatectomy for resection of a deep peritoneal implant in the round ligament of the liver during primary CRS. Among these 17 patients, hepatic parenchymal invasion was confirmed in 10 patients (58.8%). Tumor distribution of others is as follows: Glisson's capsule, hilum, falciform ligament and gall bladder. Fourteen patients (82.4%) achieved CRS; the remaining three patients had residual tumors less than 1 cm. The median period to subsequent chemotherapy was 21 days (range, 12–35 days). No specific complications related to left hepatectomy were identified such as liver failure or bile leakage. Left hemi-hepatectomy for complete surgical resection of a deep peritoneal implant of the round ligament of the liver is surgically feasible and safe.
- Subjects
LIVER histology; LIVER tumors; PATIENT safety; OVARIAN tumors; CYTOREDUCTIVE surgery; TREATMENT effectiveness; CANCER patients; RETROSPECTIVE studies; DESCRIPTIVE statistics; METASTASIS; CANCER chemotherapy; SURGICAL complications; DISEASES; MEDICAL records; ACQUISITION of data; HEPATECTOMY; SURVIVAL analysis (Biometry); LIVER blood-vessels; DISEASE complications
- Publication
Cancers, 2024, Vol 16, Issue 17, p3036
- ISSN
2072-6694
- Publication type
Article
- DOI
10.3390/cancers16173036